Search

everythinglearnresearchcommunity

for

Search:↓

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Testosterone therapy increases bone density in older men with low testosterone levels.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

A single injection of PTH–CBD can increase bone density for up to a year.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Balding men had lower bone density, while balding women had higher hip bone density.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Using gelatin sponges for deep skin wounds helps bone marrow cells repair tissue without scarring.

Strong steroid cream works better than tretinoin cream for patchy scalp hair loss.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

The skin's basement membrane has specialized structures and molecules for different tissue interactions, important for hair growth and attachment.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

Bone marrow-derived cells can lead to skin inflammation and tumors in mice.

High hair calcium levels are linked to low calcium intake and low bone density.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Testosterone plus finasteride increases bone density in men with spinal cord injuries.

Osteoporotic postmenopausal Sudanese women have a high risk of cardiovascular disease.

Fullerenes show potential in skin care but need more safety research.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Peptide hydrogel scaffolds help grow new hair follicles using stem cells.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Adequate steroid treatment needed to limit bone loss in PMR patients.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Targeting colon cancer stem cells might lead to better treatment results.